BMP Pattern Recognition Master Guide
Introduction
The Basic Metabolic Panel (BMP) represents the cornerstone diagnostic tool in nephrology and critical care. Rather than interpreting individual values in isolation, master clinicians recognize constellations of abnormalities that immediately suggest specific diagnoses. This guide teaches pattern recognition as an integrated diagnostic framework [1].
The BMP is never just seven numbers—it is a physiologic snapshot revealing the kidneys’ ability to regulate electrolytes, acid-base status, and filtration. Patterns emerge when you understand the relationships between components.
BMP Component Layout and Relationships
The traditional BMP arrangement reveals natural pathophysiologic connections:
| Component | Normal Range | Key Relationships |
|---|---|---|
| Sodium (Na) | 136-145 mEq/L | Regulates osmolality; inverse to glucose and lipids |
| Potassium (K) | 3.5-5.0 mEq/L | Affected by acid-base status and renal function |
| Chloride (Cl) | 98-107 mEq/L | Paired with Na for osmolality; inverse to HCO3 |
| HCO3 (CO2) | 23-29 mEq/L | Central to acid-base interpretation |
| BUN | 7-20 mg/dL | Kidney marker; confounded by hydration and protein intake |
| Creatinine | 0.7-1.3 mg/dL | Glomerular filtration marker; relatively stable in steady state |
| Glucose | 70-100 mg/dL (fasting) | Affects osmolality and intracellular K shifts |
Pattern 1: The Anion Gap Metabolic Acidosis (AGMA) Pattern
Diagnostic Constellation
- pH < 7.35 with HCO3 < 23
- Anion gap elevated (typically > 12 mEq/L)
- BUN and Cr usually elevated if renal cause
Anion Gap Calculation [1]
Anion Gap (AG) = Na – (Cl + HCO3)
Normal reference range: 8–16 mEq/L (varies by lab; traditionally taught as 12 ± 4, but modern labs often run 10–12)
Corrected AG for albumin: Each 1 g/dL decrease in albumin below 4.0 lowers the expected AG by 2.5 mEq/L
Differential by Anion Gap Category
| AGMA Type | Key Causes | Pattern Clues |
|---|---|---|
| Methanol/Ethylene Glycol | Toxic alcohols | High AG + high osmolal gap |
| Lactic Acidosis | Shock, liver disease, metformin, linezolid | Severe metabolic acidosis; assess lactate |
| Ketoacidosis | DKA, alcoholic, starvation | Glucose elevated (DKA), low/normal (other types); look for ketones |
| Uremia | Advanced CKD/ESRD | Elevated BUN/Cr; creatinine > 10 |
Clinical Pearl: The Osmolal Gap [2]
Calculated osmolality = 2(Na) + (BUN/2.8) + (glucose/18) + (ethanol/3.7)
Osmolal gap = Measured osmolality – Calculated osmolality
Normal: < 10 mOsm/kg water
Elevated osmolal gap > 10 → suggests unmeasured osmotically active substance (methanol, ethylene glycol, isoniazid, propylene glycol)
Board Vignette #1
A 58-year-old male presents with pH 7.18, HCO3 8, AG 24. BUN 48, Cr 2.1. Na 138, K 5.8, Cl 98. What is your initial assessment? - High AG metabolic acidosis (AG = 138 – (98 + 8) = 32) - Elevated BUN/Cr ratio (23:1) suggests prerenal component + metabolic disease - Hyperkalemia suggests renal dysfunction - Differential: Sepsis with lactic acidosis, diabetic ketoacidosis, or uremia
Pattern 2: The Non-Anion Gap Metabolic Acidosis (Hyperchloremic) Pattern
Diagnostic Constellation
- pH < 7.35 with HCO3 < 23
- Normal or slightly elevated anion gap (8–12)
- Chloride elevated relative to normal
- Approach: Calculate urine anion gap (UAG) and urine osmolal gap (UOG)
Urine Anion Gap [3]
UAG = (Urine Na + Urine K) – Urine Cl
Normal UAG (< 0): GI bicarbonate loss (diarrhea) → kidneys appropriately acidify urine Positive UAG (> 0): Renal tubular dysfunction (RTA types) → inability to acidify urine
Renal Tubular Acidosis (RTA) Subtypes
| RTA Type | Defect | Urine pH | K Status | UAG | Primary Cause |
|---|---|---|---|---|---|
| Type 1 (Distal) | α-intercalated cell proton pump dysfunction | > 5.5 (inappropriately high) | Low | Positive | Amphotericin B, hereditary |
| Type 2 (Proximal) | Proximal HCO3 reabsorption defect | Variable | Low | Negative | Carbonic anhydrase inhibitor, FS |
| Type 4 (Hypoaldosteronism) | Aldosterone deficiency/resistance | < 5.5 | High | Positive | ACE-I, NSAIDs, adrenal disease |
Type 4 RTA is the most common in adults, especially with NSAIDs and ACE inhibitors. Always check K in hyperchloremic acidosis—K directs your diagnosis.
Board Vignette #2
A 62-year-old on NSAIDs presents with pH 7.32, HCO3 19, AG 12, K 6.2, Cl 108. Urine pH 5.2, UAG +8. - Non-gap metabolic acidosis (AG normal) - Hyperchloremia + hyperkalemia → Type 4 RTA (hypoaldosteronism) - Appropriately acidic urine (pH 5.2) but positive UAG indicates renal H+ secretion defect - Management: Hold NSAIDs, monitor K, consider mineralocorticoid replacement
Pattern 3: The Metabolic Alkalosis Pattern
Diagnostic Constellation
- pH > 7.45 with HCO3 > 29
- Chloride often low (< 95)
- Determine volume status and urine chloride
Volume-Responsive vs. Volume-Resistant Alkalosis
| Feature | Volume-Responsive | Volume-Resistant |
|---|---|---|
| Urine Cl | < 10 mEq/L | > 20 mEq/L |
| Common Causes | Vomiting, diuretics (if hypovolemic) | Primary hyperaldosteronism, Cushing’s, hypokalemia-perpetuating |
| Treatment | Normal saline; replace K and Cl | Treat underlying cause; K repletion |
Common Patterns Leading to Alkalosis
Contraction Alkalosis: Vomiting/NG suction → loss of HCl and volume contraction → kidney retains HCO3 - Key clue: Low Cl, low volume status, hypokalemia
Hyperaldosteronism: HTN + hypokalemia + alkalosis - Key clue: Low K (often < 3.0), elevated BP, high urine K despite hypokalemia
Treat hypokalemic metabolic alkalosis with isotonic saline + K replacement. Normal saline provides Cl repletion, restoring glomerular filtration and reducing HCO3 reabsorption.
Board Vignette #3
A 48-year-old woman on hydrochlorothiazide presents with pH 7.52, HCO3 38, K 2.8, Cl 92. Urine Cl 8. - Metabolic alkalosis with volume contraction (low urine Cl) - Hypokalemia perpetuates alkalosis (low K drives H+ secretion in collecting duct) - Management: IV isotonic saline + 20–40 mEq K daily; hold diuretics
Pattern 4: The Acute Kidney Injury (AKI) Patterns
Pre-Renal AKI Pattern
- BUN/Cr ratio > 20:1 (e.g., BUN 40, Cr 1.6)
- K, Cl, HCO3 relatively normal initially
- Urine osmolality > 500 (concentrated urine)
Intrinsic AKI Pattern
- BUN/Cr ratio 10–15:1 (more balanced)
- K often elevated (K 5.5–7.0) due to reduced excretion
- Urine osmolality < 400 (dilute urine, lost concentrating ability)
- May see metabolic acidosis if severe
Rhabdomyolysis Pattern [4]
- Severe metabolic acidosis (pH often 7.0–7.2)
- Hyperkalemia (K often 6.5–8.0)
- Elevated BUN/Cr ratio with CK > 5,000 IU/L
- HCO3 low (< 15)
- Hallmark: Massive myoglobinuria with acute tubular necrosis
Board Vignette #4
A 24-year-old crush injury victim: pH 7.08, HCO3 12, K 7.2, Cr 2.8, BUN 35 (BUN/Cr ~12:1), CK 52,000. - Severe metabolic acidosis + hyperkalemia → myoglobinuria + rhabdomyolysis - Moderate AKI (intrinsic pattern) - Emergency management: Aggressive IV hydration (goal urine output > 200 mL/h), sodium bicarbonate (target urine pH > 6.5), monitor for compartment syndrome
Pattern 5: Tumor Lysis Syndrome (TLS)
Diagnostic Constellation [5]
- Hyperkalemia (K often > 7.0)
- Hyperphosphatemia (not on BMP but crucial)
- Hypocalcemia (secondary to hyperphosphatemia)
- Elevated uric acid and creatinine (AKI from uric acid nephropathy)
- Metabolic acidosis common
BMP Clues
- K > 6.0 in patient with hematologic or solid malignancy
- Rapid rise in Cr (often doubling within 24–48 hours)
- HCO3 may be low (acidosis from cell lysis)
Management Pearls
- Aggressive IV hydration (avoid potassium-containing fluids)
- Allopurinol or rasburicase (uric acid lowering)
- Monitoring for hyperuricemia-induced AKI
Board Vignette #5
A 42-year-old with newly diagnosed acute leukemia: K 7.8, Cr 1.9 (baseline 0.9), HCO3 22 (normal), PO4 5.8. Day-to-day Cr is rising. - Hyperkalemia + rising creatinine in setting of malignancy → Tumor Lysis Syndrome - Elevated phosphorus (not visible on standard BMP) drives secondary hypocalcemia - Intervention: Start rasburicase, IV hydration, monitor closely for cardiac dysrhythmias
Pattern 6: Ethylene Glycol and Methanol Toxicity
Diagnostic Constellation
- High AG metabolic acidosis (AG > 20)
- Elevated osmolal gap (> 10)
- HCO3 severely low (< 10)
- History of ingestion (antifreeze, windshield fluid)
Sequential Metabolic Changes
- Early phase (0–12 hours): Osmolal gap > AG (parent compound predominates)
- Later phase (> 12 hours): AG increases as toxic metabolites (glycolate, glyoxylate for ethylene glycol; formate for methanol) accumulate
The “osmolal gap first, then anion gap” pattern is pathognomonic for toxic alcohol ingestion. Early recognition allows for antidote therapy (fomepizole) before severe metabolic acidosis develops.
Board Vignette #6
A 34-year-old found down with antifreeze near him: pH 6.95, HCO3 8, AG 32. Measured osmolality 380, calculated osmolality 310 (osmolal gap 70). K 5.4, Cr 2.1. - Severe metabolic acidosis + massive osmolal gap → Ethylene glycol toxicity - Acute kidney injury from glycolate crystallization - Immediate action: Fomepizole bolus, hemodialysis, supportive care
Integration with Urinalysis
The BMP pattern gains diagnostic power when integrated with urinalysis findings [6]:
| BMP Pattern | UA Finding | Likely Diagnosis |
|---|---|---|
| High AG acidosis + hyperkalemia | Muddy brown casts | Acute tubular necrosis (rhabdomy or sepsis) |
| AGMA + hypokalemia | Glucose + ketonuria | Diabetic ketoacidosis |
| Non-gap acidosis + low K | RBCs + protein | Type 1 RTA (stone-formers, nephrolithiasis) |
| Alkalosis + hypokalemia | Bland sediment | Metabolic alkalosis from GI loss |
Delta-Delta Interpretation (Advanced Tool)
Used in high-AG metabolic acidosis to identify concurrent acid-base disorders.
Delta Gap = Anion Gap – 12 (or institution’s normal AG baseline)
Delta HCO3 = 24 – measured HCO3
Delta-Delta = Delta Gap / Delta HCO3
| Ratio | Interpretation | Meaning |
|---|---|---|
| 0.4–0.8 | Appropriate AG/∆HCO3 ratio | Pure AGMA |
| < 0.4 | ∆HCO3 falls faster than AG rises | Concurrent non-gap acidosis (RTA, diarrhea) |
| > 0.8 | ∆HCO3 lags behind AG rise | Concurrent metabolic alkalosis or respiratory alkalosis |
Board Vignette #7 (Delta-Delta)
A 55-year-old with DKA: pH 7.18, HCO3 10, AG 26, K 5.1, Cl 98. - Delta AG = 26 – 12 = 14 (significant anion gap metabolic acidosis) - Delta HCO3 = 24 – 10 = 14 (HCO3 appropriately low) - Delta-Delta = 14/14 = 1.0 → Concurrent metabolic alkalosis (likely from vomiting/volume depletion) - Clinical implication: This patient has both DKA AND contraction alkalosis; treatment must address both
Quick Reference: Five-Step BMP Interpretation Algorithm
- Calculate AG → AGMA vs. non-gap metabolic acidosis
- Check osmolal gap → Toxic ingestion? (if AG elevated and osmolal gap > 10)
- Assess BUN/Cr ratio → Pre-renal (> 20:1) vs. intrinsic (10–15:1) AKI pattern
- Evaluate K level → Guides RTA type, severity of acidosis, hyperkalemia risk
- Integrate UA findings → Casts, protein, glucose narrow differential diagnosis
Clinical Application: From Pattern to Diagnosis
| Clinical Presentation | BMP Pattern | Most Likely Diagnosis | Next Steps |
|---|---|---|---|
| Severe abdominal pain, ingestion unknown | High AG, osmolal gap 40 | Toxic alcohol (EG or methanol) | ABG, serum osmolality, fomepizole |
| Crush injury, dark urine | AGMA, K 7.2, Cr rising | Rhabdomyolysis | Urine myoglobin, CK, aggressive hydration |
| HTN, hypokalemia, alkalosis | Alk + K 2.5, pH 7.52 | Hyperaldosteronism | Renin, aldosterone ratio, imaging |
| Vomiting × 2 days | Alk, K 2.8, Cl 88, low Urine Cl | Contraction alkalosis | IV isotonic saline + K replacement |
| New-onset leukemia, K 7.8 | High K, rising Cr, normal Cl | Tumor lysis syndrome | Uric acid, phosphorus, rasburicase start |
References
[1] Kraut JA, Madias NE. “Serum anion gap: its uses and limitations in clinical medicine.” Clinical Journal of the American Society of Nephrology. 2007 Jan;2(1):162-74. PubMed
[2] Fenves AZ, Emmett M. “Approach to patients with high anion gap metabolic acidosis: Core Curriculum 2021.” American Journal of Kidney Diseases. 2021 Oct;78(4):590-600. PubMed
[3] Berend K, de Vries AP, Gans RO. “Physiological approach to assessment of acid-base disturbances.” New England Journal of Medicine. 2014 Sep 4;371(10):932-943. doi: 10.1056/NEJMra1003327. PubMed
[4] Palmer BF. “Approach to fluid and electrolyte disorders and acid-base problems.” Primary Care. 2008 Mar;35(1):1-10. doi: 10.1016/j.pop.2007.09.002. PubMed
[5] Cairo MS, Bishop M. “Tumour lysis syndrome: new therapeutic strategies and classification.” British Journal of Haematology. 2004;127(1):3-11. doi: 10.1046/j.1365-2141.2003.04915.x PubMed
[6] Simerville JA, Maxted WC, Pahira JJ. “Urinalysis: a comprehensive review.” American Family Physician. 2005 Mar 15;71(6):1153-62. PubMed